Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 5:01 AM
Ignite Modification Date:
2025-12-25 @ 5:01 AM
NCT ID:
NCT01510418
Eligibility Criteria:
Eligibility criteria for person with congenital bleeding disorder(PWCBD, men with congenital hemophilia):
* Known diagnosis of congenital hemophilia A or B with or without inhibitor (defined by a plasma factor VIII or factor IX level below lower limits of normal and medical history consistent with diagnosis).
* Male age 21 years or older
* Willing to indicate if they have a spouse or significant other.
* Able to read, write and participate in interview on site.
Exclusion Criteria for PWCBD:
* Other bleeding disorder besides congenital hemophilia A or B
Eligibility criteria for spouses/significant other (SSO) participants in the study:
* A person in a relationship for a minimum of 9 months with the PWCBD participating in the study.
* PWCBD partner must be participating in the study.
* Willing to participate in questionnaire and interview on site.
Exclusion criteria for SSO:
\- Biologically related to PWCBD participant (that is, not a parent, sibling, child or other biologically-related caregiver).
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
21 Years
Study:
NCT01510418
Study Brief:
Protocol Section:
NCT01510418